Skip to main content

Month: August 2024

Crown Castle Releases 2023 ESG Report

HOUSTON, Aug. 14, 2024 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or the “Company”) announced today the release of its 2023 Environmental, Social and Governance (“ESG”) Report and updates to its ESG website, which can be found at www.crowncastle.com/esg. “Crown Castle’s business model is providing shared assets for multiple users to bring communications connectivity to the many people, communities and businesses across the U.S. Our tower sites and fiber-fed locations deliver both sound economics and a sustainable means of meeting the growing demand for digital technology and broadband data usage,” stated Steven Moskowitz, Crown Castle’s Chief Executive Officer. “We have made terrific progress in advancing our environmental, sustainability and governance...

Continue reading

Reading International Reports Second Quarter 2024 Results

Earnings Call Webcast to Discuss Second Quarter Financial Results Scheduled to Post to Corporate Website on Friday, August 16, 2024 NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today announced its results for the Second Quarter ended June 30, 2024. Second Quarter 2024 Summary Results The anticipated lingering effects of the 2023 Hollywood Strikes negatively impacted our second quarter 2024 global box office as the movie line-up featured not only fewer blockbuster films due to changes in studio release dates, but also a number of underperforming films. The expected hit to the box office, which was most pronounced in April and...

Continue reading

Veeco Announces Agreement with IBM to Explore Wet Processing System for Advanced Packaging Applications

Veeco’s WaferStorm® Wet Processing System to Enable Essential Cleaning Processes in Hybrid Bonding for IBM PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) today announced that IBM selected the WaferStorm® Wet Processing System for Advanced Packaging applications and has entered into a joint development agreement to explore advanced packaging applications using multiple wet processing technologies from Veeco. Under the agreement, the Waferstorm Wet Processing System will be installed at facilities at the Albany NanoTech Complex in Albany, NY, where IBM and other ecosystem partners are driving leading-edge R&D in advanced packaging and chiplet technologies. The WaferStorm system enables crucial hybrid bonding cleaning processes such as resist strip, temporary bonding strip, and pre-bond...

Continue reading

GlobalTech Launches Big Data & AI Center of Excellence in Pakistan

RENO, Nev., Aug. 14, 2024 (GLOBE NEWSWIRE) — GlobalTech Corporation (OTC: GLTK) proudly announces the launch of its cutting-edge Center of Excellence dedicated to Big Data and artificial intelligence (AI) in Pakistan. This new facility marks a significant milestone in GlobalTech’s ongoing commitment to technological innovation and global market expansion. The state-of-the-art software center, which is expected to be completed by first quarter of 2025, is to be located within the premises of WorldCall Telecom Limited, a subsidiary of GlobalTech Corporation. Dan Green, GlobalTech’s President, commented on this strategic development, “Technology is at the core of GlobalTech’s business strategy, and we have been diligently working to bring this initiative to fruition. As we advance various products toward market readiness,...

Continue reading

Tevogen Bio’s Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund, Appointed Dean of the University of South Florida Health College of Public Health

WARREN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virology, congratulates Professor Sten Vermund, MD, PhD, Chairperson of Tevogen Bio’s Innovation and Public Health Advisory Board, on being named as the dean of the USF Health College of Public Health, effective January 1, 2025. In addition to his new role at the University of South Florida, Dr. Vermund will continue to serve as the President of the Global Virus Network (GVN), a nonprofit coalition of human and animal virologists from more than 80 centers of excellence in 40 countries. Under his leadership, the GVN is at the forefront of combating future pandemic...

Continue reading

Plants & Goodwin Inc., a Subsidiary of Zefiro Methane Corp., Acquires a Minority Stake in, and Obtains an Exclusive U.S. Patent License from, Winterhawk Well Abandonment Ltd.

Winterhawk develops innovative technology to optimize oil and gas well casing operations FORT LAUDERDALE, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) — Plants & Goodwin Inc. (“P&G”), a subsidiary of ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”), today announced the acquisition of a minority ownership interest in Winterhawk Well Abandonment Ltd. (“Winterhawk”) for an undisclosed amount. Winterhawk is a Calgary-based manufacturer of specialized downhole tools and technologies designed to expand casing in oil and gas wells to seal the leak pathways of surface casing vent flows. Sealing these methane leaks using conventional well decommissioning procedures is not always successful, but forward-thinking innovations patented by companies like Winterhawk can increase well...

Continue reading

Tenable Recognized as the Top Performer in Cloud Security by CRN 2024 Annual Report Card Award

Solution providers regard Tenable as the best in managed and cloud services and support COLUMBIA, Md., Aug. 14, 2024 (GLOBE NEWSWIRE) — Tenable®, the exposure management company, today announced it was named the top performer in cloud security in the 2024 CRN Annual Report Card Award from CRN®, a brand of The Channel Company. This award honors technology vendors for providing best-in-class products, partner program resources, partner support and managed and cloud services. “It is a great honor to be recognized by our partners as a trusted cloud security provider and this achievement is a testament to our collaborative commitment to joint customers,” said Jeff Brooks, senior vice president, Global Channels and Business Development, Tenable. “While ripe with business opportunity, the cloud opens organizations up to intense cyber...

Continue reading

Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System 

Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board  Collaboration to address emerging pet and public health threats to protect pets and people Early detection potential has global pet and public health benefits SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory Board will also be joined by Boehringer Ingelheim, Mars Science & Diagnostics, and other leading pet, public health and...

Continue reading

INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA

SARASOTA, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment and acquisition of fertility clinics, and with the intravaginal culture (“IVC”) procedure enabled by its INVOcell® medical device, today announced financial results for the second quarter 2024 for the period ended June 30, 2024 and provided a business update. Q2 2024 Financial Highlights (all metrics compared to Q2 2023 unless otherwise noted)Revenue was $1,836,597, an increase of 481% compared to $315,902. Revenue increased 17% sequentially compared to Q1 2024. Clinic revenue increased 611% to $1,807,921, compared to $254,364. All reported clinic revenue is derived...

Continue reading

Crown Electrokinetics Reports Second Quarter 2024 Financial Results

Second Quarter Revenues of $4.6 million up from First Quarter Revenues of $0.7 million, an increase of 582% LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber optic networks and lead pipe inspection and remediation, will report its financial results for the second quarter 2024 today, August 14, 2024. Doug Croxall, Crown CEO and Chairman, “Our second quarter represents our best revenue quarter in our history. As of today, we have eliminated all investment debt and all classes of our preferred equity; thereby cleaning up both our balance sheet and cap table significantly. We have added to our senior management team and announced two new lines of business with lead pipe inspection and remediation....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.